Christel Menet
Chief Scientific Officer Confo Therapeutics
Christel joined Confo Therapeutics as Chief Scientific Officer in 2016. Prior to that, Christel was Director of Medicinal Chemistry at Galapagos (2014–2016). Earlier in her career, Christel held medicinal chemistry roles at Evotec, Faust Pharmaceuticals (now Domain Therapeutics), and contributed to multiple drug discovery programs, advancing several compounds into preclinical and clinical development. Christel is an inventor on over 25 patent applications and hold a PhD in Organic Chemistry from the University of Manchester under Prof. Jonathan Clayden.
Seminars
Wednesday 10th December 2025
Engineering Antibody Agonists to Transform GPCR Targeting With Durable Biologics
4:45 pm
- Stabilising GPCRs in active conformations to enable the generation of functional antibody agonists, a key hurdle in expanding biologic modalities for these targets
- Recognising the limitations of current GPCR antibodies which are predominantly antagonists or binders, and investing in technologies that support agonist development
- Leveraging the advantages of antibody agonists such as improved pharmacokinetics, longer half-life, and scalable manufacturing to create more durable and patient friendly therapies
